MedTrace Logo

Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid

NCT00636220 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2015-08-17

Study results available
· View outcomes & findings →

Summary

This protocol is intended to test the feasibility of using the HIV 1/2 STAT-PAK and the DPP HIV 1/2 test (with and without the DPP Handheld Reader) to detect HIV antibodies in oral fluids.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • University of Maryland

    collaborator OTHER

  • Chembio Diagnostic Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • Niel Constantine, PhD · University of Maryland, Baltimore

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00636220 on ClinicalTrials.gov